Expert Pitch
Rutgers University-New Brunswick

Rutgers Expert Available to Discuss the Emotional Toll of Social Distancing

20-Mar-2020 8:35 AM EDT, by Rutgers University-New Brunswick

As people continue to self-isolate in the face of the COVID-19 pandemic, they are at higher risk for the more negative aspects of emotional isolation, which for many can result in confusion, anger, sadness and in more extreme cases symptoms not unlike those seen in post-traumatic stress, said Frank A. Ghinassi, president and CEO of Rutgers University Behavioral Health Care.

“Many of these symptoms, and their severity, are mediated by whether those who are quarantined are doing so voluntarily — “I don’t feel so well, and I really don’t want to make anyone else sick” — or because of a national, enforced emergency lock-down, by the extent and richness of their baseline social support network, and by their access to accurate and timely news, that is non-alarmist information,” Ghinassi said. “The endlessly repetitive information that often pervades the 24-hour news cycle can worsen stress.”

Other contributors to increased symptoms in the face of isolation are a lack of access to basic needs, including in-adequate housing, clothing, food and water, needed medical prescriptions and lack of an ability to stay connected via internet, social medial, phone, facetime and other technological connection tools. “For many, social isolation includes not being able to get to work, and as a result can mean financial loss and insecurity as an added stressor,” he said. “There is also stigma felt by those under quarantine. They feel like they are to blame and labeled as somebody who needs to be avoided.”

Since the degree to which social isolation can affect people often depends on their pre-existing social connectedness, people tend to be especially concerned about stay-at-home seniors who rely on others for daily needs or those who are live alone with little in the way of support networks, he noted.

Millennials who consider social media “followers” as “friends” often report feeling isolated without the daily interactions they have with people at work or in their community which is often the place where most face to face interaction occurs. “Many individuals in 2020 too often mistake Twitter and Instagram “counts” as a viable substitution for face to face, intimate friendships, and it really is several degrees of linkage away,” said Ghinassi who recommends people re-connect with family members or friends via phone or video chat during these stressful times.

Bio: https://ubhc.rutgers.edu/about-us/leadership/frank-ghinassi.xml




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
3.60161